UnitedHealth Group Receives “Positive” Rating from Susquehanna (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “positive” rating reiterated by equities research analysts at Susquehanna in a research note issued to investors on Wednesday, AR Network reports. They currently have a $84.00 target price on the stock, up from their previous target price of $81.00. Susquehanna’s target price points to a potential upside of 17.52% from the stock’s previous close.
The analysts wrote, “We expect the managed care group will post solid third quarter results beginning when UNH kicks of earnings on October 17. The earnings period will matter for the group as Humana will offer specific EPS guidance for 2014 and others, particularly UNH, are likely to offer at least some preliminary expectations for next year.”
UnitedHealth Group (NYSE:UNH) traded up 0.12% during mid-day trading on Wednesday, hitting $71.565. 1,015,075 shares of the company’s stock traded hands. UnitedHealth Group has a 52 week low of $51.09 and a 52 week high of $75.88. The stock has a 50-day moving average of $72.73 and a 200-day moving average of $66.81. The company has a market cap of $72.760 billion and a price-to-earnings ratio of 13.61.
UnitedHealth Group (NYSE:UNH) last released its earnings data on Thursday, July 18th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.25 by $0.15. The company had revenue of $30.40 billion for the quarter, compared to the consensus estimate of $30.48 billion. During the same quarter in the previous year, the company posted $1.27 earnings per share. The company’s revenue for the quarter was up 11.5% on a year-over-year basis. On average, analysts predict that UnitedHealth Group will post $5.50 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Deutsche Bank raised their price target on shares of UnitedHealth Group from $68.00 to $71.00 in a research note to investors on Tuesday. They now have a “hold” rating on the stock. Separately, analysts at TheStreet reiterated a “buy” rating on shares of UnitedHealth Group in a research note to investors on Tuesday. Finally, analysts at Ned Davis Research downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 30th. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $76.67.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.